Rebecca Aida Guzman of Duane Morris. Courtesy photo.. Rebecca Aida Guzman of Duane Morris. Courtesy photo..

Rebecca Aida Guzman, Duane Morris

In July 2022, Guzman was promoted to the firm's partnership in an off-cycle promotion (a move that the firm has not made in over 20 years). The fashion in which Guzman was promoted exemplifies the valued contributions that she brings to Duane Morris.

Guzman has counseled several life sciences companies through exciting inflection points over the past few years, including: the representation of a biopharmaceutical company based in Malvern, Pennsylvania, developing next-generation antibiotics in several financing transactions, including a Series C Preferred Stock Financing; a medical device startup, also based in Malvern, Pennsylvania, in its Series A Preferred Stock financing, as well as other strategic initiatives; and a pharmaceutical company focusing on concentration disorders of the kidney, in its initial corporate structuring and capitalization.

Many anticipated deals were put on pause during the pandemic. How did you overcome these obstacles?